2021
Genetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States
Azar MM, Cohen E, Ma L, Cissé OH, Gan G, Deng Y, Belfield K, Asch W, Grant M, Gleeson S, Koff A, Gaston DC, Topal J, Curran S, Kulkarni S, Kovacs JA, Malinis M. Genetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States. Clinical Infectious Diseases 2021, 74: 639-647. PMID: 34017984, PMCID: PMC9012955, DOI: 10.1093/cid/ciab474.Peer-Reviewed Original ResearchConceptsKidney transplant recipientsCases of PCPPneumocystis pneumoniaClinic visitsRisk factorsClinic exposureLow absolute lymphocyte countRisk of PCPAbsolute lymphocyte countFrequent clinic visitsPneumocystis jirovecii pneumoniaStrong risk factorNon-white raceCase-control analysisBelatacept groupMonthly infusionsTransplant recipientsBaseline characteristicsJirovecii pneumoniaLymphocyte countMultilocus sequence typingInterhuman transmissionRespiratory specimensUnivariate analysisEpidemiologic data
2016
Ambulatory Blood Pressure in Patients with Chronic Kidney Disease
Asch W, Santos S, Peixoto A. Ambulatory Blood Pressure in Patients with Chronic Kidney Disease. Clinical Hypertension And Vascular Diseases 2016, 277-298. DOI: 10.1007/978-3-319-22771-9_14.Peer-Reviewed Original ResearchChronic kidney diseaseKidney diseaseImportant cardiovascular disease risk factorsCardiovascular disease risk factorsChronic kidney disease progressionHome blood pressure monitoringAbnormal BP profileOffice BP measuresKidney disease progressionAmbulatory blood pressureDisease risk factorsBlood pressure monitoringOffice BPBP profileBlood pressureEssential hypertensionAdverse outcomesBP measuresDisease burdenRisk factorsDisease progressionGeneral populationPressure monitoringPatientsDisease
2015
Renal cancer in kidney transplanted patients
Frascà GM, Sandrini S, Cosmai L, Porta C, Asch W, Santoni M, Salviani C, D’Errico A, Malvi D, Balestra E, Gallieni M. Renal cancer in kidney transplanted patients. Journal Of Nephrology 2015, 28: 659-668. PMID: 26202137, DOI: 10.1007/s40620-015-0219-8.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCalcineurin inhibitorsRenal cancerNative kidneysKidney diseaseWithdrawal of CNIsChronic allograft nephropathyAutosomal dominant polycystic kidney diseaseDominant polycystic kidney diseaseGeneral risk factorsCystic kidney diseasePolycystic kidney diseaseAllograft nephropathyImmunosuppressive therapyRapamycin inhibitorsUltrasound evaluationDialysis treatmentRisk factorsCystic diseaseGeneral populationPatientsMalignancy susceptibilityCancer developmentMammalian targetCancerKidney